Computational fluid dynamics modeling, a novel, and effective approach for developing scalable cell therapy...

Area of Science:

• Biotechnology
• Regenerative Medicine
• Chemical Engineering

Background:

• Induced pluripotent stem cells (iPSCs) offer potential for cell therapies but current manufacturing methods are not scalable.
• Existing scale-up approaches for cell therapies are empirical and do not accurately model 3D bioreactor hydrodynamics.
• This leads to increased costs and development time for clinical and commercial cell therapy production.

Purpose of the Study:

• To develop a scalable manufacturing process for high-quality iPSC derivatives.
• To implement computational fluid dynamics (CFD) modeling for effective scale-up in 3D bioreactors.
• To demonstrate comparability between small-scale and scaled-up cell differentiation processes.

Main Methods:

• Utilized computational fluid dynamics (CFD) modeling to predict and optimize scale-up parameters.
• Employed a Good Manufacturing Practice (GMP)-compatible iPSC line for process translation.
• Scaled up a cardiomyocyte differentiation protocol from a small-scale system to a 3-L computer-controlled bioreactor.

Main Results:

• Successfully translated and scaled up an iPSC-based cardiomyocyte differentiation process.
• CFD modeling provided an effective strategy for scaling up cell therapy manufacturing.
• The scaled-up process in the 3-L bioreactor demonstrated comparability to the small-scale system.

Conclusions:

• CFD modeling offers a novel, efficient approach to scale up cell therapy manufacturing in 3D bioreactors.
• This method overcomes limitations of traditional empirical scale-up, reducing cost and time.
• The demonstrated successful scale-up supports the clinical and commercial viability of iPSC-derived therapies.